Go Pro
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

BIO-key International logo
$2.81 -0.01 (-0.35%)
As of 09/4/2026 04:00 PM Eastern

About BIO-key International Stock (NASDAQ:BKYI)

Advanced

Key Stats

Today's Range
$2.66
$2.96
50-Day Range
$2.81
$5.89
52-Week Range
$2.66
$19.70
Volume
23,830 shs
Average Volume
72,484 shs
Market Capitalization
$4.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

BIO-key International, Inc. is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems. Its solutions support use cases in healthcare, financial services, education, retail and public sector agencies, where reliable and auditable authentication is required. BIO-key also offers cloud-based multi-factor authentication services, enabling remote and hybrid workforces to access critical applications securely.

Headquartered in Wall Township, New Jersey, BIO-key maintains a presence in North America as well as partnerships in Europe and Asia to distribute its biometric products and services internationally. The company emphasizes ongoing research and development in biometric algorithms, user interface design and mobile integration in order to respond to evolving cybersecurity threats.

The executive leadership team is led by Chief Executive Officer Mike DePasquale, who brings experience in identity management and software commercialization. Under this leadership, BIO-key continues to pursue partnerships, channel expansions and product enhancements aimed at broadening the adoption of fingerprint authentication across industry verticals.

AI Generated. May Contain Errors.

BIO-key International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

BKYI MarketRank™: 

BIO-key International scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BIO-key International has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    BIO-key International has only been the subject of 2 research reports in the past 90 days.

  • Read more about BIO-key International's stock forecast and price target.
  • Earnings Growth

    Earnings for BIO-key International are expected to grow in the coming year, from ($1.62) to $0.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BIO-key International is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BIO-key International is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BIO-key International has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about BIO-key International's valuation and earnings.
  • Percentage of Shares Shorted

    1.00% of the float of BIO-key International has been sold short.
  • Short Interest Ratio / Days to Cover

    BIO-key International has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BIO-key International has recently decreased by 78.45%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BIO-key International does not currently pay a dividend.

  • Dividend Growth

    BIO-key International does not have a long track record of dividend growth.

  • News Sentiment

    BIO-key International has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for BIO-key International this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BIO-key International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    4.00% of the stock of BIO-key International is held by insiders.

  • Percentage Held by Institutions

    26.51% of the stock of BIO-key International is held by institutions.

  • Read more about BIO-key International's insider trading history.
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BKYI Stock News Headlines

This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more electricity than an entire office building. One new chip, which looks more like a piece of plywood than a processor, delivers similar performance on a fraction of the power. Tech investing veteran George Gilder says that efficiency gap could decide who wins the next stage of AI. Gilder has identified three companies positioned around this power breakthrough, calling them the Trillion Dollar Triangle.tc pixel
See More Headlines

BKYI Stock Analysis - Frequently Asked Questions

BIO-key International's stock was trading at $5.3910 on January 1st, 2026. Since then, BKYI shares have decreased by 47.9% and is now trading at $2.81.

BIO-key International Inc. (NASDAQ:BKYI) issued its quarterly earnings results on Thursday, August, 13th. The technology company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.82) by $0.26. The technology company earned $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative trailing twelve-month return on equity of 67.31% and a negative net margin of 50.01%.
Read the conference call transcript
.

Shares of BIO-key International reverse split before market open on Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include ExxonMobil (XOM), T2 Biosystems (TTOO), Nokia (NOK), Tonix Pharmaceuticals (TNXP) and

Company Calendar

Last Earnings
8/13/2026
Today
9/06/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Software
Sub-Industry
Systems Software
Current Symbol
NASDAQ:BKYI
CIK
1019034
Employees
50
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($4.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.16 million
Net Margins
-50.01%
Pretax Margin
-87.79%
Return on Equity
-67.31%
Return on Assets
-40.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.26
Quick Ratio
1.14

Sales & Book Value

Annual Sales
$6.09 million
Price / Sales
0.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.02 per share
Price / Book
0.93

Miscellaneous

Outstanding Shares
1,440,000
Free Float
1,379,000
Market Cap
$4.05 million
Optionable
No Data
Beta
0.40

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:BKYI) was last updated on 9/6/2026 by MarketBeat.com Staff.
From Our Partners